Humana has released details about additional, upcoming organizational improvements to encourage a faster prior authorization process, lessen system waste and increase transparency.
Humana announced today several internal and external improvements they will make to reduce the red tape surrounding prior authorizations, according to a news release. By the end of 2026, they plan to reduce prior authorization requirements, establish a faster process for approvals and create a national gold card program for physicians with a consistent track record.
Two of these changes will be in effect by January 1, 2026. Humana will eliminate approximately one-third of prior authorizations for outpatient services, including diagnostic services such as colonoscopies, select CT scans and MRIs. Humana also pledges to provide a coverage decision within one business day on at least 95% of all complete electronic prior authorization requests. Humana currently provides a decision within one business day on more than 85% of outpatient procedures, according to the news release.
A national gold card program will also be available for physicians in 2026. This card will waive certain prior authorization requirements for physicians with a proven record of high-quality care and who submit coverage requests in a timely manner.
In 2026, Humana will also publicly report its prior authorization metrics, which will include data on approved and denied requests, as well as requests approved after appeal and the average time between submission and decision.
“Today’s healthcare system is too complex, frustrating, and difficult to navigate, and we must do better,” Jim Rechtin, president and CEO of Humana, said in the news release. “We are committed to reducing prior authorization requirements and making this process faster and more seamless to better support patients, caregivers, physicians and healthcare organizations.”
Humana is currently working to improve interoperability and decrease administrative burdens by improving physicians’ electronic healthcare workflows to reduce turnaround times and by accepting more prior authorization requests electronically. Industry-wide, nearly half of prior authorization requests for prescription drugs (47%) and medical services (45%) are done manually by physicians, according to a survey from America's Health Insurance Plans (AHIP).
Today’s announcement builds upon last month’s commitment, where more than 50 health insurance companies, including Humana, pledged to streamline the prior authorization processes using six new commitments:
“These measurable commitments—addressing improvements like timeliness, scope and streamlining—mark a meaningful step forward in our work together to create a better system of health,” Kim Keck, president and CEO, Blue Cross Blue Shield Association, said in last month’s news release.
These changes are expected to benefit approximately 257 million Americans across insurance markets, including those with commercial coverage, Medicare Advantage or Medicaid.
Approximately 25% of healthcare spending is considered unnecessary, thanks to overtreatment, outdated technology and fraud, according to a JAMA Network article. A Pew Research Survey shows that the cost of healthcare is among the top three biggest concerns for Americans, with 89% expressing concern.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Gene Therapy for Rare Eye Disease to Advance to Human Trial
July 22nd 2025The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene therapy for boys with blue cone monochromacy, which impairs color vision and severely affects visual function.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Gene Therapy for Rare Eye Disease to Advance to Human Trial
July 22nd 2025The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene therapy for boys with blue cone monochromacy, which impairs color vision and severely affects visual function.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
2 Commerce Drive
Cranbury, NJ 08512